
U.S Protein Expression Systems Market Size, Share, By Product Type (Reagents, Expression Vectors/Plasmids, Competent Cells and Instruments), System Type (Prokaryotic Expression Systems, and Eukaryotic Expression Systems), Application (Therapeutic Protein
Description
U.S Protein Expression Systems Market Size, Share, By Product Type (Reagents, Expression Vectors/Plasmids, Competent Cells and Instruments), System Type (Prokaryotic Expression Systems, and Eukaryotic Expression Systems), Application (Therapeutic Protein Production, Research Applications, Industrial Enzymes, Diagnostics, and Others), End User (Pharmaceutical and Contract Research Organizations (CROs), Academic and Research Institutes, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and Others), Trends, Analysis, and Forecast till 2035
The U.S Protein Expression Systems Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
The U.S protein expression systems market that involves technologies for producing functional proteins in various host cells as such systems are crucial for applications in drug development, academic research and biotechnology. U.S. protein expression systems have large scale usage in producing therapeutic proteins, enzymes, and vaccines along with supporting structural biology, molecular biology and functional genomics in their research activities.
Report Highlights:
In October 2024, Phase I clinical trial of PRX-115 data was introduced by Protalix BioTherapeutics their recombinant PEGylated uricase product candidate was developed using their proprietary ProCellEx plant cell-based protein expression system.
In September 2024, a joint partnership with Novartis was announced by Generate: Biomedicines, which is a Cambridge, Massachusetts-based biotechnology company specializing in machine learning for protein design that aims to leverage Generate's generative AI platform to develop novel protein therapeutics, reflecting the growing integration of artificial intelligence in protein engineering and protein expression systems.
Report Analysis:
Trends in U.S Protein Expression Systems Market:
Advancement in biotechnology and expansion of biopharmaceutical R&D for enhancing the efficiency and yield of protein production for cost effective protein expression systems and further increasing the focus on extensive research and development activities in the biopharmaceutical sector for development of novel therapeutics by adopting protein expression technologies. Current trends include dominance of mammalian expression systems that is gaining prominence due to their ability to produce complex proteins for therapeutic applications.
Segmentation:
By Product Type:
Agilent Technologies, Inc.
Ajinomoto Bio-Pharma?
Lonza.
Merck KGaA
New England Biolabs
GenScript
Sigma-Aldrich Chemicals Private Limited
Sino Biological, Inc.
Promega Corporation
Evitria AG
ProteoGenix
Bio-Techne
Ventria Bioscience Inc.
Boster Biological Technology
Biocompare
What Our Report Offers:
FAQs:
Key Questions Answered in the Report.
1. What was the U.S Protein Expression Systems Market size in 2025?
2. What is projected growth rate of the U.S Protein Expression Systems Market during 2025-2035?
3. What are the key factors driving the U.S Protein Expression Systems Market growth?
4. What are leading players in the U.S Protein Expression Systems Market?
5. What are the key regions analyzed in the U.S Protein Expression Systems Market?
6. Which region is dominating in the U.S Protein Expression Systems Market?
The U.S Protein Expression Systems Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
The U.S protein expression systems market that involves technologies for producing functional proteins in various host cells as such systems are crucial for applications in drug development, academic research and biotechnology. U.S. protein expression systems have large scale usage in producing therapeutic proteins, enzymes, and vaccines along with supporting structural biology, molecular biology and functional genomics in their research activities.
Report Highlights:
- U.S protein expression systems market size is accounted for USD 2.2 Billion in 2025.
- Target market size is estimated to be valuated at USD 6.1 Billion by 2035 and at a registered CAGR of 5.89 %.
- By Product type, Reagents is the dominant product segment in the U.S protein expression systems market share
- By Application, the therapeutic protein production segment is expected to influence the U.S protein expression systems market share.
- By end-user, the pharmaceutical and biotechnology companies is the end user ruling over the U.S protein expression systems market share.
In October 2024, Phase I clinical trial of PRX-115 data was introduced by Protalix BioTherapeutics their recombinant PEGylated uricase product candidate was developed using their proprietary ProCellEx plant cell-based protein expression system.
In September 2024, a joint partnership with Novartis was announced by Generate: Biomedicines, which is a Cambridge, Massachusetts-based biotechnology company specializing in machine learning for protein design that aims to leverage Generate's generative AI platform to develop novel protein therapeutics, reflecting the growing integration of artificial intelligence in protein engineering and protein expression systems.
Report Analysis:
Trends in U.S Protein Expression Systems Market:
Advancement in biotechnology and expansion of biopharmaceutical R&D for enhancing the efficiency and yield of protein production for cost effective protein expression systems and further increasing the focus on extensive research and development activities in the biopharmaceutical sector for development of novel therapeutics by adopting protein expression technologies. Current trends include dominance of mammalian expression systems that is gaining prominence due to their ability to produce complex proteins for therapeutic applications.
Segmentation:
By Product Type:
- Reagents
- Expression Vectors/Plasmids
- Competent Cells
- Instruments
- Prokaryotic Expression Systems
- Eukaryotic Expression Systems
- Therapeutic Protein Production
- Research Applications
- Industrial Enzymes
- Diagnostics
- Others
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Contract Manufacturing Organizations (CMOs)
- Others
Agilent Technologies, Inc.
Ajinomoto Bio-Pharma?
Lonza.
Merck KGaA
New England Biolabs
GenScript
Sigma-Aldrich Chemicals Private Limited
Sino Biological, Inc.
Promega Corporation
Evitria AG
ProteoGenix
Bio-Techne
Ventria Bioscience Inc.
Boster Biological Technology
Biocompare
What Our Report Offers:
- Regional & Country-Specific Market Intelligence: Gain a competitive edge with in-depth market share breakdowns across critical regions and nations, helping you identify growth opportunities and strategic positioning.
- Strategic Entry Support for New Entrants: Expert-backed recommendations to navigate market entry challenges, establish a strong presence, and accelerate growth in unfamiliar markets.
- Accurate Long-Term Market Projections: Trusted forecasts spanning 2025 to 2035, including key milestones for 2025, 2026, and 2030, empowering data-driven decision-making for sustainable investments.
- Comprehensive Market Trend Analysis: A deep dive into market drivers, barriers, emerging opportunities, and potential risks, alongside insights into high-growth investment areas and industry challenges.
- Actionable Business Strategies: Data-powered recommendations customized for key market segments, supported by rigorous market assessments to maximize profitability.
- Competitive Landscape Mapping: Uncover prevailing industry trends, competitor tactics, and untapped opportunities to refine your market approach and stay ahead.
- Exclusive Company Profiles: Detailed evaluations of leading market players, covering business models, financial health, strategic moves, and recent advancements.
- Next-Gen Supply Chain Trends: Cutting-edge insights into technological innovations revolutionizing supply chain operations, enhancing efficiency, and reducing costs.
FAQs:
Key Questions Answered in the Report.
1. What was the U.S Protein Expression Systems Market size in 2025?
2. What is projected growth rate of the U.S Protein Expression Systems Market during 2025-2035?
3. What are the key factors driving the U.S Protein Expression Systems Market growth?
4. What are leading players in the U.S Protein Expression Systems Market?
5. What are the key regions analyzed in the U.S Protein Expression Systems Market?
6. Which region is dominating in the U.S Protein Expression Systems Market?
Table of Contents
169 Pages
- Us Protein Expression Systems Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By System Type
- Market Snippet, By Application
- Market Snippet, By End Use
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Type Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Collaboration and Partnerships
- New Product Launch
- Market Segmentation, By Product Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Reagents
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Expression Vectors/Plasmids
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Competent Cells
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Instruments
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By System Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Prokaryotic Expression Systems
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Eukaryotic Expression Systems
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Therapeutic Protein Production
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Research Applications
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Industrial Enzymes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnostics
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End User, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Pharmaceutical and Contract Research Organizations (CROs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Academic and Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Research Organizations (CROs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Manufacturing Organizations (CMOs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Other
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.